Eddine Saiah
Chief Executive Officer Stablix
Seminars
Wednesday 28th October 2026
The Journey to DUBTAC Clinical Candidates
2:15 pm
- Discussing DUB selection
- Candidate identification and characterization
- Explaining and demonstrating efficacy versus safety
Tuesday 27th October 2026
Panel Discussion: Navigating the Evolving Induced Proximity Landscape: Trends, Opportunities & Global Impact
9:00 am
- Examining recent advances across degrader and non-degrader modalities, highlighting how new discoveries are moving the field beyond oncology
- Assessing the influence of global markets, including China, on drug development, the clinical landscape and strategic collaborations in induced proximity therapeutics
- Identifying emerging opportunities, bottlenecks, and the next frontiers in translating platform innovations into clinically relevant therapies
